Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AKTX | Ordinary Shares, par value $0.0001 per share | Award | $1.19M | +1.33B | +56.88% | $0.00* | 3.66B | May 31, 2024 | Direct | F1, F2 |
holding | AKTX | Ordinary Shares, par value $0.0001 per share | 38.7M | May 31, 2024 | Praxis Trustees Limited | F1 | |||||
holding | AKTX | Ordinary Shares, par value $0.0001 per share | 801M | May 31, 2024 | RPC Pharma Limited | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AKTX | Warrants (Right to Buy) | Award | $1.19M | +1.33B | $0.00* | 1.33B | May 31, 2024 | Ordinary Shares, par value $0.0001 per share | 1.33B | $0.00 | Direct | F1, F2, F3 |
Id | Content |
---|---|
F1 | The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents 2,000 Ordinary Shares. |
F2 | On May 31, 2024, the Reporting Person acquired 1,326,258,000 Ordinary Shares and accompanying warrants to purchase up to 1,326,258,000 Ordinary Shares in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of May 29, 2024. The combined purchase price was $0.0009425 per Ordinary Share and accompanying warrant. |
F3 | The warrants have an exercise price of $0.000895 per Ordinary Share. |
See Exhibit 24.1 - Power of Attorney